The National Amyotrophic Lateral Sclerosis Registry
The purpose of this registry is to (A) better describe the incidence and prevalence of Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors, such as environmental and occupational, that may be associated with the disease; (C) better outline key demographic factors (such as age, race
| Condition(s) | Amyotrophic Lateral Sclerosis |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The purpose of this registry is to (A) better describe the incidence and prevalence of Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors, such as environmental and occupational, that may be associated with the disease; (C) better outline key demographic factors (such as age, race or ethnicity, gender, and family history of individuals who are diagnosed with the disease) associated with the disease; and (D) better examine the connection between ALS and other motor neuron disorders that can be confused with ALS, misdiagnosed as ALS, and in some cases progress to ALS. |
| Who can participate | Inclusion Criteria: \- U.S. citizens 18 years of age or older Exclusion Criteria: \- |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Centers for Disease Control and Prevention |
| Locations | Atlanta, Georgia, United States |
| Start date | 2010-10 |
| NCT ID | NCT01772602 |
| Official listing | https://clinicaltrials.gov/study/NCT01772602 |